Long-term drug treatment of panic disorder

https://doi.org/10.1016/0022-3956(93)90022-TGet rights and content

Abstract

Drug treatment of panic disorder with benzodiazepines and antidepressants has been established as efficacious in the short-term (6–8 weeks). The efficacy of medications during long-term (i.e, continuous) treatment has not often been addressed and a review of the evidence is presented. Most data exists for the long-term effectiveness of benzodiazepines. Experience with the triazolobenzodiazepine, alprazolam, is reviewed together with some other high potency drugs, e.g, clonazepam. Tricyclic antidepressants are also effective in the long-term treatment of panic and the relevant studies are presented. Long-term efficacy for monoamine oxidase inhibitors is not as clearly established. The issue of relapse following drug withdrawal is addressed and some strategies for patient management in long-term therapy are discussed.

References (71)

  • J.C. Ballenger et al.

    Alprazolam in panic disorder and agoraphobia: Results from a multicentre trial. I: Efficacy in short-term treatment

    Archives of General Psychiatry

    (1988)
  • P. Beaudry et al.

    Bromazepam, another high-potency benzodiazepine for panic attacks

    American Journal of Psychiatry

    (1984)
  • J.L. Browne et al.

    A review of alprazolam withdrawal

    Drug Intelligence and Clinical Pharmacy

    (1986)
  • J. Buigues et al.

    Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks

    Journal of Clinical Psychiatry

    (1987)
  • D.S. Charney et al.

    Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam and trazodone

    Journal of Clinical Psychiatry

    (1986)
  • D.S. Charney et al.

    Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam

    Journal of Clinical Psychiatry

    (1989)
  • G. Chouinard et al.

    Alprazolam in the treatment of generalised anxiety and panic disorders: a double-blind placebo controlled study

    Psychopharmacology

    (1982)
  • Committee on the Review of Medicines

    Systematic review of the benzodiazepines

    British Medical Journal

    (1980)
  • Boer J.A. Den et al.

    Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoamine

    International Clinical Psychopharmacology

    (1987)
  • D.L. Dunner et al.

    Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study

    Journal of Clinical Psychiatry

    (1986)
  • R.L. DuPont et al.

    Alprazolam withdrawal in panic disorder patients

    New research Abstracts of the 138th Annual Meeting of the American Psychiatric Association

    (1985)
  • P.M.G. Emmelkamp et al.

    Agoraphobia: a follow-up study four years after treatment

    British Journal of Psychiatry

    (1979)
  • L. Evans et al.

    Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks: A double-blind comparison of zimelidine, imipramine and placebo

    Acta Psychiatrica Scandinavica

    (1986)
  • L.F. Fabre et al.

    Comparison of the therapeutic effect, tolerance and safety of ketazolam and diazepam administered for six months to outpatients with chronic anxiety n eurosis

    Journal of International Medical Research

    (1981)
  • R. Fontaine et al.

    Antipanic effect of clonazepam

    American Journal of Psychiatry

    (1984)
  • A.J. Fyer et al.

    Discontinuation of alprazolam treatment in panic patients

    American Journal of Psychiatry

    (1987)
  • H. Garakani et al.

    Treatment of panic disorder with imipramine alone

    American Journal of Psychiatry

    (1984)
  • J.M. Gorman et al.

    An open trial of fluoxetine in the treatment of panic attacks

    Journal of Clinical Psychopharmacology

    (1987)
  • D.J. Greenblatt et al.

    Current status of the benzodiazepines

    New England Journal of Medicine

    (1983)
  • D.J. Greenblatt et al.

    Dependence, tolerance and addiction to benzodiazepines: clinical and pharmacokinetic considerations

    Drug Metabolism Reviews

    (1978)
  • C. Hallstrom et al.

    Benzodiazepine withdrawal phenomenon

    International Pharmacopsychiatry

    (1981)
  • J.B. Herman et al.

    The alprazolam to clonazepam switch for the treatment of panic disorder

    Journal of Clinical Psychopharmacology

    (1987)
  • F.K. Judd et al.

    A short-term open clinical trial of clobazam in the treatment of patients with panic attacks

    International Clinical Psychopharmacology

    (1989)
  • F.K. Judd et al.

    Pharmacological treatment of panic disorder

    International Clinical Psychopharmacology

    (1986)
  • F.K. Judd et al.

    Pharmacotherapy of panic disorder

    International Review of Psychiatry

    (1990)

    • Cited by (21)

    • Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: Behavioral studies with concomitant in vivo CA<inf>1</inf> hippocampal norepinephrine and serotonin release detection in the behaving animal

      1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry

    • Panic in Australia

      1998, European Psychiatry

    • Evidence-based pharmacotherapy of panic disorder: An update

      2012, International Journal of Neuropsychopharmacology

    • The Rational-Choice Theory of Neurosis: Unawareness and an Integrative Therapeutic Approach

      2010, Journal of Psychotherapy Integration

    • Antidepressants plus benzodiazepines for adults with major depression

      2019, Cochrane Database of Systematic Reviews

    • Mechanisms underlying tolerance after long-term benzodiazepine use: A future for subtype-selective GABAA receptor modulators?

      2012, Advances in Pharmacological Sciences
    View all citing articles on Scopus
    View full text
    Copyright © 1994 Published by Elsevier Inc.